Authors
Latest:
The Nurse's Role in Recruitment and Retention of Clinical Trial ParticipantsRecruiting patients to participate in clinical trials is a challenging and time-consuming endeavor, especially when it comes to cancer clinical trials.
Latest:
AJMC Study Looks at the Shaky Foundation of the Patient-centered Medical HomeThe patient-centered medical home has been proposed as a solution to the challenges facing primary care, but there are several concerns over whether this approach is feasible.
Latest:
Lessons Learned from My Doctor-PatientsA doctor writes on his experiences in treating colleagues in his psychiatry practice, and the humility he's gained from it.
Latest:
Case-Based Peer Perspectives in Fabry DiseaseDawn Laney, MS, CGC, CCRC, Assistant Professor and Director, Emory Genetic Clinical Trials Center, talks misdiagnosis in Fabry disease through a case study.
Latest:
Keeping Patients Safe from Methadone Overdose: A Pharmacist's PerspectiveConfusion between methadone and other medications with lookalike names can cause life-threatening errors.
Latest:
Chemotherapy Foundation Symposium OverviewThis year's Chemotherapy FoundationSymposium, entitled
Latest:
Provide Your Patients with an Online Resource You can Both Trust...Your Own!Patients are going online for health information but would prefer to get it from you. Are you there to help them?
Latest:
White-coat hypertension and progression to home hypertensionOur study aimed to clarify whether white-coat hypertension represents a transient state in the development of hypertension outside medical settings. We followed up 128 subjects with white-coat hypertension and compared their risk of progression to home hypertension with that of 649 sustained normotensive subjects. After 8 years of follow-up, subjects with white-coat hypertension had an approximately 3-fold higher risk of eventually manifesting home hypertension. We concluded that patients with white-coat hypertension should be carefully monitored.
Latest:
Daily Antituberculosis Therapy Superior for Pulmonary TB in PLWHA daily, 6-month ATT regimen in HIV-positive patients with TB receiving concomitant ART proved superior to an intermittent regimen in terms of efficacy and prevention of ARR.
Latest:
Early Chemotherapy for Ovarian Cancer Relapse Based on Serial CA-125 Monitoring does Not Improve Overall Survival or Quality of LifeEarly chemotherapy for relapsed ovarian cancer based on serial monitoring of CA-125 levels failed to improve overall survival or quality of life compared with delayed therapy according to clinical signs and symptoms of relapse in a large European trial.
Latest:
Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardiaThe effects of recurrent tachycardia after resolution of cardiomyopathy have not been thoroughly assessed. We evaluated and followed 24 patients with tachycardia-induced cardiomyopathy for more than 12 years. Our observations showed that patients with tachycardia-induced cardiomyopathy may be at long-term risk for sudden death. Surreptitious cardiomyopathy due to occult ultrastructural changes may persist. It has yet to be determined whether rapid and aggressive rate control would prevent structural damage to risk of sudden cardiac death.
Latest:
ADHD Drugs and AddictionA community pharmacist shares his insights and opinions on concerns over the risks involved with ADHD medications for children.
Latest:
Hypertension in the elderlyMore important than the choice of pharmaceutical agent in the treatment of elderly hypertensive patients is the achievement of goal blood pressure. Low-dose diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and calcium channel blockers are equally effective in reducing cardiovascular end points. Most patients will require 2 or more drugs to achieve target blood pressure, and physicians should feel comfortable prescribing 3 to 4 agents to a significant proportion of patients.
Latest:
Sex-related differences in treatment and outcome in patients with ACSThe AMIS (Acute Myocardial Infarction in Switzerland) Plus prospective cohort study compared treatment and in-hospital outcomes between men and women with acute coronary syndrome (N = 26,452) admitted to Swiss hospitals between 1997 and 2007. The study reached several important conclusions: women had different baseline characteristics than men at admission, were treated with different drug regimens, and were significantly less likely to undergo percutaneous coronary intervention. After adjusting for these differences, researchers found no significant difference in the rates of in-hospital mortality between men and women, except for women aged 51 to 60 years, who were more likely to die in-hospital.
Latest:
Vodou Baby--the Birth of a SurgeonA Haitian nurse offered advice: "Keep your textbook nearby".
